10 results on '"Höflich K"'
Search Results
2. 384P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC
3. 1296P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC
4. P2.03-44 BLU-667 Demonstrates Robust Activity in RET Fusion-Driven Intracranial Tumor Models
5. 378 Differential Targeting of KRAS and BRAF Mutant Tumors Using MEK Inhibitors with Distinct Mechanisms of Action
6. 343 Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of squamous NSCLC cells
7. 205 Distinct inhibitory properties of MEK inhibitors on pathway feedback translate into differential potency in BRAF and RAS mutant cancer cells
8. 142 GDC-0941 PI3K inhibitor activity in preclinical lung cancer models
9. 132 Intermittent dosing of the MEK inhibitor, GDC-0973, and the PI3K inhibitor, GDC-0941, results in prolonged accumulation of Bim and causes strong tumor growth inhibition in vivo
10. P.6.002 Behavioral phenotyping of GSK-3 beta knockout heterozygote mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.